Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Invasive Urothelial Carcinoma: Subtypes and Divergent Differentiation

In: Urologic Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 12. Chapter 1.
Affiliations
Free Books & Documents
Review

Invasive Urothelial Carcinoma: Subtypes and Divergent Differentiation

Michelle R. Downes.
Free Books & Documents

Excerpt

Invasive urothelial carcinoma is the most frequent type of bladder cancer and may occur in pure or classical form or with the presence of variant or subtype histology and/or evidence of divergent morphology such as squamous, glandular, or trophoblastic differentiation. Increasingly, it is recognized that certain subtypes impact patient prognosis and outcome hence the need to correctly recognize and document their presence. Certain subtypes and divergent features correlate with the emerging molecular bladder cancer subtypes, which can also influence patient management decisions. The pathologist therefore plays a crucial role in providing clinically relevant information, mostly derived from hematoxylin and eosin slides, which will guide urologists and oncologists in terms of risk stratification and treatment planning.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The author declares no potential conflicts of interest with respect to research, authorship and/or publication of this chapter.

References

    1. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 https://doi.org/10.1002/ijc.33588 . - DOI - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33. https://doi.org/10.3322/caac.21654 . - DOI - PubMed
    1. Moch H, Humphrey PA, Ulbright TM, Reuter V. International Agency for Research on Cancer. 4th Edition ed. Lyon, France: Infiltrating Urothelial Carcinoma; 2016. WHO Classification of Tumours of the Urinary System and Male Genital Organs; pp. 81–98.
    1. Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE, et al. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol. 2014;45:1473–1482. https://doi.org/10.1016/j.humpath.2014.02.024 . - DOI - PubMed
    1. Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010;34:1367–1376. https://doi.org/10.1097/PAS.0b013e3181ec86b3 . - DOI - PubMed

LinkOut - more resources